Figure 3.
Risks and 1-year burdens of incident post-acute COVID-19 dyslipidaemia outcomes compared with the contemporary control cohort by care setting of the acute infection
Risks and burdens were assessed at 1 year in mutually exclusive groups comprising non-hospitalised individuals with COVID-19, individuals hospitalised for COVID-19, and individuals admitted to intensive care for COVID-19 during the acute phase (first 30 days) of COVID-19. Outcomes were ascertained 30 days after the COVID-19-positive test until the end of follow-up. The contemporary control cohort served as the reference category. Within the COVID-19 cohort, there were those who were non-hospitalised, hospitalised, and admitted to intensive care. Adjusted hazard ratios and 95% CIs are presented. The length of the bar represents the excess burden per 1000 people at 1 year and related 95% CIs are also presented.